ucsf banner
Home    :   Contact Us
Hiroyo Hatano, MD

Hiroyu Hatano, MD, MHS
Assistant Adjunct Professor

Attending physician, Positive Health Practice, SFGH

Research Interests
HIV-infected "elite" controllers; HIV viral persistence

Select Publications

1) Hatano H and Deeks SG. Drug-resistant HIV. BMJ 2007;334:1124-5
2) Hu ZX, Hatano H, Hammond SP, et al. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. J Acquir Immune Defic Syndr 2007;45:494-50
3) Hatano H, Hunt P, Weidler J, et al. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive regimen. Clin Infect Dis 2006;43:1329-36
4) Hatano H, Vogel S, Yoder C, et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS 2000;14(10):1357-1363
5) Hatano H, Miller KD, Yoder CP, et al. Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy (HAART). AIDS 2000;14(13):1935-1942

View PubMed results for Hiroyu Hatano, MD, MHS

Education & Training

BA, Harvard University, Cambridge, MA, 1995

Masters in Health Sciences, Duke University, Durham, NC, 2000

MD, Stanford Medical School, Stanford, CA, 2001

Internal Medicine Residency, Brigham and Women's Hospital, 2001 - 2004

Infectious Diseases Fellowship, University of California at San Francisco, 2004 - 2007